5. Mok, T. et al. Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722....
[1] Reck M, Schenker M, Lee KH , et al. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial. Eur J Ca...
Chen JJW, Chang GC. The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan. Target Oncol. 2022 May;17(3...
[9] Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.[J]. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 201...
[3]Kobayashi Y,Mitsudomi T.Not all epidermal growth factor receptor mutations in lung cancer are created equal:Perspectives for individualized treatment strategy.Cancer Sci.2016;107(9):1179-86.doi:10.1111/cas.12996. [4]Robichaux JP,Elamin YY,Tan Z,et al.Mechanisms and clinical activity of an...
参考文献:Tian HX, Chen ZH, Jie GL, Wang Z, Yan HH, Wu SP, Zhang SL, Lu DX, Zhang XC, Wu YL. Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. Cancer Med. 2022 Jun 14. doi: 10.1002/cam4.4925. Epub ahead of print. PMID...
10. Paez J G, Jänne P A, Lee J C, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004, 304(5676): 1497-1500. 11. Lynch T J, Bell D W, Sordella R, et al. Activating mutations in the epidermal growth factor receptor unde...
9.Saito H, Fukuhara T, Furuya N, et al. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial[J]. The Lancet Oncology, 2019, 20(...
Hirsch FR,et al.,Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in NonCSmall-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy,J Clin Oncol. 2008 Jul 10;26(20):3351-7. Douillard JY,et al., Relationship Between EGFR Expression, EG...
Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers (Basel). 2021 Sep 30;13(19):4926. Li T, Pang X, Wang J, Wang S, Guo Y, He N, Xing P, Li J. Exploration of the Tumor-Suppressive ...